Expressions of caspase-14 in human middle ear cholesteatoma

Laryngoscope

Volumn 118, Issue 6, 2008, Pages 1047-1050

  Jung, Myung Ho ^a   Lee, Jang Hyeog ^a   Cho, Jae Gu ^a   Jung, Hak Hyun ^a   Hwang, Soon Jae ^a   Chae, Sung Won ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Caspase 14; Cholesteatoma

Indexed keywords

CASPASE 14;

ADULT; ARTICLE; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL AUDITORY CANAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CASPASE 14; CHOLESTEATOMA, MIDDLE EAR; EAR CANAL; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 44649083149     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181671b4d     Document Type: Article

References (12)

1. Miyao M, Shinoda H, Takahashi S. Caspase-3, caspase-8, and nuclear factor-kappa B expression in human cholesteatoma. Otol Neurotol 2006;27:8-13.
2. Shinoda H, Huang CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation and programmed cell death. Laryngoscope 1995;105:1232-1237.
3. Huisman MA, De HE, Grote JJ. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol 2003;123:377-382.
4. Chien AJ, Presland RB, Kuechle MK. Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. Biochem Biophys Res Commun 2002;296:911-917.
5. Hu S, Snipas SJ, Vincenz C, Salvesen G, Dixit VM. Caspase-14 is a novel developmentally regulated protease. J Biol Chem 1998;273:29648-29653.
6. Walsh DS, Borke JL, Singh BB, et al. Psoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formation. J Dermatol Sci 2005;37:61-63.
7. Eckhart L, Declercq W, Ban J, et al. Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 2000;115:1148-1151.
8. Svane-Knudsen V, Halkier-Sorensen L, Rasmussen G, Ottosen PD. Cholesteatoma: a morphologic study of stratum corneum lipids. Acta Otolaryngol 2001;121:602-606.
9. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003;22:8543-8567.
10. Fischer H, Stichenwirth M, Dockal M, et al. Stratum corneum-derived caspase-14 is catalytically active. FEBS Lett 2004;577:446-450.
11. Chae SW, Song JJ, Suh HK, Jung HH, Lim HH, Hwang SJ. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium. Laryngoscope 2000;110:1898-1901.
12. Koenig U, Sommergruber W, Lippens S. Aberrant expression of caspase-14 in epithelial tumors. Biochem Biophys Res Commun 2005;335:309-313.